The CLDN16 gene helps the kidneys hold on to magnesium and calcium as urine is made. This gene plays an important role in keeping these minerals balanced and supporting healthy kidney tissue. If it does not work properly, you can develop an inherited kidney condition that causes low magnesium in the blood, too much calcium in the urine, kidney stones, or calcium buildup in the kidneys. Over time, some people also develop reduced kidney function.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do much of the work. Others mainly guide when certain processes take place, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can read more in LearnHub.
Overview
CLDN16Gene function
What if the gene works
The CLDN16 gene helps kidney tubules reclaim magnesium and calcium from urine. Its protein forms part of tight junctions, which control mineral movement between cells. This supports healthy mineral balance.
Risk
What if the gene does not work
Pathogenic variants in the CLDN16 gene usually cause a kidney salt handling condition with low magnesium, high urine calcium, kidney calcification, and declining kidney function. Milder or more severe variants can affect when it starts and how severe it becomes.
Treatment
What does that mean for your treatment
No CLDN16-specific treatment or management approach is currently established. Drug choices are not currently tailored to the CLDN16 gene itself, and care is supportive rather than gene-directed.
Conditions associated with CLDN16
Gene function
What if the gene works
Inside the kidneys, CLDN16 helps fine tune how minerals move back into the body after blood is filtered. Its protein sits at the borders between certain kidney tubule cells and controls which charged particles can pass through. This helps explain how the CLDN16 gene works in the kidney to support magnesium and calcium balance.
The CLDN16 gene helps build tight junctions, which are seal-like connections between neighboring kidney tubule cells. These borders keep the tubule lining organized while still allowing selected minerals to pass in a controlled way.
Inside these cell borders, its protein forms a pathway that helps the kidneys take magnesium back from the forming urine. This supports normal magnesium levels for muscles, nerves, and many everyday cell functions.
By shaping how charged particles move between kidney cells, the CLDN16 gene also supports calcium reabsorption. It works with other tight junction proteins so mineral movement stays selective and balanced.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CLDN16 gene can make the claudin-16 protein fold poorly, break down early, or miss tight junctions (the seals between neighboring kidney cells). As a result, CLDN16 gene variants affect kidney magnesium handling by leaving the protein partly active or not active at all. Milder variants may keep function, while disruptive variants can remove most of it. When both gene copies are strongly affected, familial hypomagnesemia with hypercalciuria and nephrocalcinosis often starts earlier and may be more pronounced.
How variants are linked to conditions
Pathogenic variants in the CLDN16 gene cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis, an inherited kidney condition with low magnesium in the blood, high calcium loss in urine, and calcium buildup in the kidneys. When doctors assess CLDN16 gene variants and kidney disease, this is the main established diagnosis. Many affected people develop kidney stones or worsening kidney function over time, and some progress to chronic kidney disease.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant linked with a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CLDN16, risk is changed mainly by inheritance: it is much higher if both parents carry a harmful CLDN16 change, or if a close family member is affected. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of developing this inherited kidney condition.
Inheritance of CLDN16 variants
For families asking about the CLDN16 gene inheritance pattern, CLDN16-related kidney conditions are inherited in an autosomal recessive way. This means a person usually develops the condition only if they inherit 2 disease-causing variants in the CLDN16 gene, 1 from each parent. Parents who each carry 1 variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with no familial variant. Sons and daughters are affected equally.
What does my CLDN16 result mean for my family?
Changes in the CLDN16 gene are linked to a kidney condition that usually runs in families in a recessive pattern, so close relatives may also be carriers even if they feel well. Brothers and sisters may have a higher chance of having the condition or carrying the same gene change. For many families, this means relatives may want to learn whether the same result is present, especially if there is a history of kidney stones, calcium buildup in the kidneys, or low magnesium.
Genetic information
Genetic testing
How you find out about variants
Variants in the CLDN16 gene are usually found through genetic testing for CLDN16 variants, using a blood sample or cheek swab. A lab reads the gene’s DNA code and checks for changes linked to inherited kidney salt handling conditions. Results may confirm a diagnosis, support family testing, or show that no clearly relevant variant was found.
When should I consider getting a genetic test?
Consider testing for changes in the CLDN16 gene if you or your child has very low magnesium, too much calcium in the urine, repeated kidney stones, calcium buildup in the kidneys, or early kidney problems without a clear cause. Testing can also help when these kidney findings run in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals depends on the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines because the body absorbs, breaks down, transports, and reacts to drugs in slightly different ways. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. These differences are common and are one of several factors, along with age, kidney and liver function, other medicines, and overall health, that can shape medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. It looks for links between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a drug works and how the body handles it. This information can support more informed, personalized treatment decisions. To learn more about this topic, more information is available in the LearnHub.
Drugs influenced by the CLDN16 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. If you have concerns about side effects, new symptoms, or whether a treatment is a good fit for you, talk with your doctor.
History
Families and communities once noticed patterns of kidney problems and low magnesium that seemed to run from parent to child. In the late 1990s, researchers linked these cases to the CLDN16 gene, helping explain a rare inherited kidney condition now called familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Early reports connected the condition to chromosome 3, and from these first observations, research expanded steadily until the exact gene was identified. This was an important step because it moved the field from describing symptoms to confirming a genetic cause. Over time, descriptions became more precise as additional CLDN16 variants were reported in affected families around the world. These historical steps shaped today’s understanding of inherited kidney salt handling and rare genetic kidney disease.